|
Market Closed -
Nasdaq
21:00:00 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 20.56 USD | +1.58% |
|
-3.38% | -10.65% |
| 09-20 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
| 08-10 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DMRA | Delayed | |
CBOE
| DMRA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bullish |
| Resistance | 24.21 | 26.27 | 34.14 |
| Spread/Res. | -15.08% | -21.74% | -39.78% |
| Spread/Supp. | +5.17% | +5.17% | +62.40% |
| Support | 19.55 | 19.55 | 12.66 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
